Neuroone Medical Technologies is trading at $1.96 (+5.95%) as the stock recovers from several consecutive down sessions, tracking a broader lift in U.S. equity futures.
- The move appears to be driven by positive market sentiment rather than company-specific catalysts, as no new earnings, FDA updates, or deal announcements were reported.
- Broader U.S. indices and the healthcare sector are trading higher, supporting a risk-on environment for medical technology equities.